All terms
RegulatoryRegulated Pathways
Combination Product
Product comprised of two or more regulated components - e.g., drug-device, biologic-device.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Per 21 CFR 3.2(e), a combination product is composed of two or more different types of medical products (drug, device, biologic) that are physically, chemically, or otherwise combined or co-packaged.What this means in practice
FDA assigns a lead center based on the product's primary mode of action. Combination products must comply with both drug GMPs and device QSR/QMSR via streamlined cGMP requirements at 21 CFR Part 4.Primary references
3 sourcesLink health: 3 verified· last checked 2026-05-09
FDA·1eCFR·1European Commission·1
- 1
Combination ProductsVerifiedFDAfda.gov
- 2
21 CFR Part 4VerifiedeCFRecfr.gov
- 3
European Commission - Medical DevicesVerifiedEuropean Commissionhealth.ec.europa.eu
Inline markers like [1] jump to the matching reference above.